| 000 | 01841 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513121358.0 | ||
| 264 | 0 | _c19970710 | |
| 008 | 199707s 0 0 eng d | ||
| 022 | _a0006-4971 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMeloni, G | |
| 245 | 0 | 0 |
_aBlast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation. _h[electronic resource] |
| 260 |
_bBlood _cJun 1997 |
||
| 300 |
_a4659 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Comment; Letter; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAmsacrine _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 |
_aAutoimmune Diseases _xcomplications |
| 650 | 0 | 4 |
_aBlast Crisis _xcomplications |
| 650 | 0 | 4 | _aBone Marrow Transplantation |
| 650 | 0 | 4 |
_aCarmustine _xadministration & dosage |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 |
_aCytarabine _xadministration & dosage |
| 650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIdarubicin _xadministration & dosage |
| 650 | 0 | 4 |
_aImmunologic Factors _xtherapeutic use |
| 650 | 0 | 4 |
_aInterferon-alpha _xtherapeutic use |
| 650 | 0 | 4 |
_aLeukemia, Myelogenous, Chronic, BCR-ABL Positive _xcomplications |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 |
_aPrednisone _xadministration & dosage |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 | _aTransplantation, Autologous |
| 650 | 0 | 4 |
_aVincristine _xadministration & dosage |
| 700 | 1 | _aCapria, S | |
| 700 | 1 | _aVignetti, M | |
| 700 | 1 | _aMandelli, F | |
| 700 | 1 | _aModena, V | |
| 773 | 0 |
_tBlood _gvol. 89 _gno. 12 _gp. 4659 |
|
| 999 |
_c9173389 _d9173389 |
||